GRI Bio, Inc.
GRI
$1.46
-$0.05-3.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 37.05% | 37.88% | 28.12% | -152.15% | -305.25% |
| Total Depreciation and Amortization | -2,600.00% | -163.64% | -85.71% | -88.24% | -92.00% |
| Total Amortization of Deferred Charges | -- | -100.00% | -100.00% | -31.57% | 869.59% |
| Total Other Non-Cash Items | -25.10% | -116.67% | -81.08% | -22.59% | -26.00% |
| Change in Net Operating Assets | -126.67% | -162.81% | -153.95% | -44.97% | 10.89% |
| Cash from Operations | 4.22% | -184.79% | -263.18% | -570.08% | -728.57% |
| Capital Expenditure | -- | 100.00% | 100.00% | -166.67% | -166.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 100.00% | -166.67% | -166.67% |
| Total Debt Issued | -- | -100.00% | -100.00% | -100.00% | -6.19% |
| Total Debt Repaid | -- | 100.00% | 100.00% | 100.00% | 30.36% |
| Issuance of Common Stock | 13.07% | -6.31% | -14.70% | -- | -- |
| Repurchase of Common Stock | -- | 99.19% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 24.98% | 128.94% | 134.39% | -935.10% | -2,085.48% |
| Cash from Financing | 9.58% | 75.12% | 61.86% | 603.16% | 972.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.99% | -62.83% | -67.56% | 725.23% | 2,320.99% |